PLSE
(NASDAQ)
6.64
+0.4598  (+6.92%)
Volume (24h): 54,092.00 Day Range: 6.08 - 6.85
Market Cap: 138.28M 52W Range: 5.11 - 17.84
Mar-17-20 08:05PM Pulse Biosciences Grants Equity Incentive Awards to New EmployeesBusiness Wire
Mar-16-20 08:05PM Pulse Biosciences Reports Fourth Quarter and Full Year 2019 Financial ResultsBusiness Wire
06:30PM Pulse Biosciences, Inc. to Host Earnings CallACCESSWIRE
Mar-09-20 08:46PM Pulse Biosciences Schedules Fourth Quarter and Full Year 2019 Financial Results Conference Call for March 16, 2020Business Wire
Feb-14-20 01:23PM The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices OfferingBenzinga
Feb-13-20 10:44PM Pulse Biosciences Provides Update on FDA 510(k) Submission for the CellFX System in DermatologyBusiness Wire
Jan-30-20 02:41AM Pulse Biosciences to Present Data on Nano-Pulse Stimulation Technology for Nodular Basal Cell Carcinoma at IMCAS World Congress 2020Business Wire
Jan-20-20 04:07PM What You Must Know About Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Beta ValueSimply Wall St.
Dec-30-19 11:35AM Pulse Biosciences Sees Hammer Chart Pattern: Time to Buy?Zacks
Dec-18-19 02:00PM Pulse Biosciences Updates on Regulatory ProgressBusiness Wire
Dec-16-19 10:26PM Pulse Biosciences Grants Equity Incentive Awards to New EmployeesBusiness Wire
Nov-19-19 01:32AM Pulse Biosciences Grants Equity Incentive Awards to New EmployeesBusiness Wire
Nov-07-19 08:44PM Pulse Biosciences Announces Transition of Chief Financial OfficerBusiness Wire
08:42PM Pulse Biosciences Quarterly Investor Conference CallBusiness Wire
Oct-31-19 05:51PM Pulse Biosciences to Report Third Quarter 2019 Operational Highlights and Financial ResultsBusiness Wire
Oct-22-19 03:53PM Is Pulse Biosciences (NASDAQ:PLSE) In A Good Position To Deliver On Growth Plans?Simply Wall St.
Oct-17-19 11:52PM Pulse Biosciences Presents Data From Several Clinical Studies of Nano-Pulse Stimulation Technology™ to Clear Skin Lesions at the 2019 ASDS Annual MeetingBusiness Wire
Oct-15-19 11:40PM Pulse Biosciences Grants Equity Incentive Awards to New EmployeesBusiness Wire
Oct-01-19 08:34PM Pulse Biosciences Announces Scientific Presentations of Nano-Pulse Stimulation™ Technology at Key Medical Aesthetic MeetingsBusiness Wire
Sep-18-19 01:02AM Pulse Biosciences Grants Equity Incentive Awards to New EmployeesBusiness Wire
Aug-21-19 02:16PM Could Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Investor Composition Influence The Stock Price?Simply Wall St.
Aug-09-19 08:24AM Pulse Biosciences, Inc Common Stock (PLSE) Q2 2019 Earnings Call TranscriptMotley Fool
Aug-08-19 08:02PM Pulse Biosciences Quarterly Investor Conference CallBusiness Wire
Aug-06-19 12:00PM Pulse Biosciences Announces Podium Presentation of Nano-Pulse Stimulation™ Technology at Major Aesthetic Procedures ConferenceBusiness Wire
May-23-19 05:44PM Is Pulse Biosciences's (NASDAQ:PLSE) 189% Share Price Increase Well Justified?Simply Wall St.
May-01-19 02:24AM Pulse Biosciences, Inc. (PLSE) Q1 2019 Earnings Call TranscriptMotley Fool
Apr-30-19 08:34PM Pulse Biosciences Quarterly Investor Conference CallBusiness Wire
Apr-17-19 11:27PM Pulse Biosciences to Report First Quarter 2019 Operational Highlights and Financial ResultsBusiness Wire
Pulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)